search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Contract manufacturing


Repairing a fragile


supply chain


he healthcare supply chain has long been fragmented and complex. The Covid-19 pandemic showed how fragile global healthcare supply chains really are, but even before the pandemic, original equipment manufacturers (OEMs) within the medical device industry had been subject to a range of issues – predominantly centred around the procurement of raw materials from a range of sources, leading to a supply chain that is reliant on many different players and countries.


T


The cost of supplies is one of the biggest expenses for OEMs because of these supply chain issues, and the situation has not improved in recent years as ongoing trade tensions, tariffs and geopolitical instability have continued to affect suppliers. OEMs need to be leaner and more agile given current global events, so many have started to onshore production with the help of contract development and manufacturing organisations (CDMOs). In the long run, this switch will help to stabilise the supply chain for many companies without needing to invest significant capital in their own infrastructure, reducing the risks and costs associated with onshore manufacturing. Medical device manufacturers are part of a fragmented and fragile supply chain, where surges in demand are often hard to predict. Surgeons only request medical devices when they are needed because unused devices must go through rigorous decontamination stages if they are to return to the supply chain. This can lead to shortages if materials and components are not easily available at the time of need, but it is also hard to keep a


20 www.medicaldevice-developments.com


From rare earth choke points and geopolitical flashpoints to paediatric


device shortages, the medical device supply chain has never been more exposed. Partnering with contract development and manufacturing organisations (CDMOs), OEMs are reshoring production, navigating complex regulations and building in redundancy – trading capex- heavy plants for flexible, localised networks that promise greater resilience when the next disruption hits. Liam Critchley speaks


to Professor Tinglong Dai of Johns Hopkins University about contract manufacturing and supply chain resilience.


gualtiero boffi/Shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100